Advertisement
EDAP Новости Форекс
EDAP TMS Says FDA Grants Breakthrough Designation To Focal One For Rectal Endometriosis
EDAP TMS SA (EDAP) announced Monday that its Focal One platform has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA) for the treatment of deep infiltrating endometriosis (DIE).
RTTNews
|
519 дней спустя
